Lipaglyn Tablet is used to treat diabetic dyslipidemia (a condition characterized by increased triglyceride levels, low-density lipoproteins (LDL)) in type 2 diabetic patients, which is not controlled by statins (lipid-lowering agents) alone. Diabetic dyslipidaemia is characterised by increased triglyceride levels, low-density lipoproteins (LDL) and decreased high-density lipoprotein (HDL) levels. This condition is common in people with type-2 diabetes mellitus.

Lipaglyn Tablet contains Saroglitazar; it works in two ways in your body. It assists in lowering blood levels of harmful fats by reducing bad cholesterol. It improves insulin sensitivity, which helps regulate blood sugar levels by increasing your body's reactivity to insulin. Lipaglyn Tablet helps control blood sugar and cholesterol levels by performing these two things, which is particularly advantageous for diabetics

In some cases, you may experience certain common side effects, such as stomach inflammation, nausea, vomiting, weakness, chest discomfort, dizziness, and fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are recommended to consult your doctor if you experience these side effects persistently.

Take Lipaglyn Tablet as advised. Your physician will decide the dosage based on your medical condition. You can take Lipaglyn Tablet before the first meal or as advised by the doctor. It is recommended not to exceed the recommended dose of Lipaglyn Tablet . Do not chew, crush, or break the medicine. It is crucial to have your blood sugar levels checked regularly.

Inform your doctor if you are allergic to Lipaglyn Tablet or any other components present in it. Lipaglyn Tablet should be used with caution in patients with kidney or liver impairment and in elderly patients. Avoid alcohol consumption while taking Lipaglyn Tablet as it might cause unpleasant side effects. Consult your doctor if you are pregnant or breastfeeding. Lipaglyn Tablet should not be given to children as safety and effectiveness have not been established. Lipaglyn Tablet might cause dizziness, so drive with caution.

Lipaglyn Tablet is used in the treatment of diabetic dyslipidaemia/hypertriglyceridemia. The detailed uses of Lipaglyn Tablet are as follows:

• Diabetic Dyslipidemia: Lipaglyn Tablet helps regulate cholesterol levels in people with diabetes by lowering triglycerides and LDL (bad cholesterol) while increasing HDL (good cholesterol).
• Hypertriglyceridemia: Lipaglyn Tablet reduces high triglyceride levels, which are linked to cardiovascular risks.
• Type 2 Diabetes Mellitus: Lipaglyn Tablet improves insulin sensitivity and helps control blood sugar levels.
• Non-Alcoholic Fatty Liver Disease (NAFLD): Lipaglyn Tablet helps in managing fat accumulation in liver cells, potentially preventing progression to more severe conditions.

• Lipaglyn Tablet is to be taken before the first meal of the day, or as advised by the doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow Lipaglyn Tablet as a whole with a glass of water.
• Do not chew, crush or break it.

• Lipaglyn Tablet helps reduce triglyceride levels considerably, total cholesterol, LDL (bad cholesterol), VLDL, and non-HDL-C.
• It is especially useful in diabetic and atherogenic dyslipidemia.
• Reduces HbA1c and fasting plasma glucose in type 2 diabetes.
• Useful in patients who require simultaneous management of glucose and cholesterol levels.
• Potentially beneficial in lowering hepatic steatosis and fibrosis.
• Improving cholesterol and glucose levels may minimize overall cardiovascular risk in diabetes people.
• However, long-term cardiovascular outcome investigations are either ongoing or limited.

• Do not take Lipaglyn Tablet if you are allergic to any of the components.
• Inform your doctor if you notice rapid weight gain.
• Maintain caution if you have any history of kidney or liver impairment or use in elderly patients.
• Consult your doctor before taking Lipaglyn Tablet if you are pregnant. It is not known if Lipaglyn Tablet is excreted into breast milk; therefore, nursing mothers should avoid taking Lipaglyn Tablet while nursing.
• Lipaglyn Tablet should be used with caution in patients with type 2 diabetes who have cardiovascular disease.
• Lipaglyn Tablet is not recommended for use in children below 18 years of age, as safety and effectiveness have not been established.
• Lipaglyn Tablet might cause dizziness, so drive with caution. Avoid alcohol consumption while taking Lipaglyn Tablet as it might cause unpleasant side effects.
• It is always important to check the expiry date of the medicine. Discard the medicine if it reaches the expiry date.